OTCMKTS:EDTXF Spectral Medical (EDTXF) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free EDTXF Stock Alerts $0.33 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.33▼$0.3350-Day Range$0.30▼$0.4252-Week Range$0.18▼$0.50Volume19,008 shsAverage Volume19,754 shsMarket Capitalization$91.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Spectral Medical alerts: Email Address Ad Behind the MarketsFidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>> About Spectral Medical Stock (OTCMKTS:EDTXF)Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.Read More EDTXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EDTXF Stock News HeadlinesMay 4, 2024 | americanbankingnews.comApyx Medical (NASDAQ:APYX) versus Spectral Medical (OTCMKTS:EDTXF) Head-To-Head AnalysisApril 10, 2024 | finanznachrichten.deSpectral Medical Inc.: Spectral Medical Provides Tigris Trial UpdateMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.April 10, 2024 | globenewswire.comSpectral Medical Provides Tigris Trial UpdateApril 1, 2024 | finance.yahoo.comSpectral Medical Full Year 2023 Earnings: Misses ExpectationsMarch 29, 2024 | finanznachrichten.deSpectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate UpdateMarch 28, 2024 | globenewswire.comSpectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate UpdateMarch 7, 2024 | msn.comNovel method improves Fourier transform infrared spectroscopy detection of ultra-low concentration trace substancesMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.February 28, 2024 | globenewswire.comSpectral Medical Provides February Tigris Trial UpdateFebruary 25, 2024 | morningstar.comSpectral Medical Inc EDTXFFebruary 21, 2024 | msn.comBaxter extends distribution deal with Spectral for sepsis productFebruary 21, 2024 | finance.yahoo.comSpectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare CorporationFebruary 15, 2024 | finanznachrichten.deSpectral Medical Inc.: Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 PatientsFebruary 5, 2024 | msn.comAstronomers inspect a peculiar pulsating variable white dwarfFebruary 5, 2024 | finance.yahoo.comSpectral Medical Provides Early February Tigris Trial UpdateJanuary 9, 2024 | theglobeandmail.comClosing Bell: Spectral Medical Inc flat on Monday (EDT)December 30, 2023 | finance.yahoo.comSpectral Medical (TSE:EDT) shareholders have earned a 6.2% CAGR over the last five yearsDecember 1, 2023 | finance.yahoo.comSpectral Medical Announces CFO DepartureNovember 27, 2023 | tmcnet.comSpectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of DirectorsOctober 31, 2023 | msn.comSpectral AI files to sell 8.43M shares for holdersOctober 16, 2023 | finance.yahoo.comSpectral Medical Announces Opening of Tigris Clinical Trial Site at the Mayo ClinicOctober 2, 2023 | finance.yahoo.comSpectral Medical Provides Board UpdateSeptember 20, 2023 | benzinga.comSpectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare ConferenceSeptember 13, 2023 | finance.yahoo.comSpectral Medical Supports World Sepsis DaySeptember 7, 2023 | finance.yahoo.comCORRECTION – Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note FinancingAugust 16, 2023 | theglobeandmail.comClosing Bell: Spectral Medical Inc down on Tuesday (EDT)See More Headlines Receive EDTXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today5/08/2024Next Earnings (Estimated)5/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:EDTXF Previous SymbolOTCMKTS:DIAGF CUSIPN/A CIKN/A Webwww.spectraldx.com Phone(416) 626-3233Fax416-626-7383Employees29Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,600,000.00 Net Margins-974.16% Pretax Margin-970.27% Return on EquityN/A Return on Assets-210.60% Debt Debt-to-Equity RatioN/A Current Ratio0.40 Quick Ratio0.37 Sales & Book Value Annual Sales$1.18 million Price / Sales77.59 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-8.22Miscellaneous Outstanding Shares278,640,000Free Float274,464,000Market Cap$91.56 million OptionableNot Optionable Beta0.82 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Christopher SetoCEO & DirectorDr. John A. Kellum M.D.Chief Medical OfficerKey CompetitorsBlueRiver AcquisitionNYSE:BLUAAllurion TechnologiesNYSE:ALURBrainsWayNASDAQ:BWAYKORU Medical SystemsNASDAQ:KRMDNeuroneticsNASDAQ:STIMView All Competitors EDTXF Stock Analysis - Frequently Asked Questions How have EDTXF shares performed in 2024? Spectral Medical's stock was trading at $0.32 at the beginning of the year. Since then, EDTXF stock has increased by 3.1% and is now trading at $0.33. View the best growth stocks for 2024 here. Are investors shorting Spectral Medical? Spectral Medical saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 71,500 shares, an increase of 8.8% from the March 15th total of 65,700 shares. Based on an average trading volume of 86,000 shares, the short-interest ratio is presently 0.8 days. View Spectral Medical's Short Interest. When is Spectral Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our EDTXF earnings forecast. How were Spectral Medical's earnings last quarter? Spectral Medical Inc. (OTCMKTS:EDTXF) issued its earnings results on Thursday, March, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. The business earned $0.27 million during the quarter. How do I buy shares of Spectral Medical? Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EDTXF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.